Global Voice Prosthesis Devices Market Drivers
Increasing prevalence of laryngeal cancer is expected to drive global voice prosthesis devices market growth over the forecast period. Moreover, laryngeal cancer has certain comorbidities such as ear pain. According to the American Cancer Society (ASC), in the U.S, around 12,410 adults were diagnosed with laryngeal cancer in 2019.
Moreover, in 2019, according to the NIDCD (National Institute on Deafness and Other Communication Disorders), in the U.S, around 7.5 million people faced problem of voice production through the voice box. In addition, individuals who are aged between 30 to 50 years face first sign of the spasmodic dysphonia (spasms of voice box), mostly in women than men. Therefore, increasing number of patient suffering from the laryngeal cancer coupled with growing prevalence of the voice generation problem are expected to boost global voice prosthesis market growth over the forecast period.
The companies operating in the global voice prosthesis devices market are focused on acquisitions, which is expected to drive the growth of global voice prosthesis devices market. For instance, in 2018, Atos Medical AB acquired high-quality tracheostomy products of Heimomed Heinze GmbH & Co. KG. This acquisition helped Atos Medical AB to expand its product portfolio in Germany as well in Australia. These factors are expected to fuel global voice prosthesis devices market growth over the forecast period.
Global Voice Prosthesis Devices Market Key Players
Key players operating in the global voice prosthesis devices market include Atos Medical AB, InHealth Technologies, Smiths Medical, Inc., Servona GmbH, Teleflex Incorporated, HEIMOMED Heinze GmbH & Co. KG, Andreas Fahl Medizintechnik Vertrieb GmbH, and Hood Laboratories.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients